Brief: Cancer Genetics Announces 1-For-30 Reverse Stock Split
24/10/2019 13:36
Oct 24 (Reuters) - Cancer Genetics Inc CGIX.O :
* CANCER GENETICS ANNOUNCES 1-FOR-30 REVERSE STOCK SPLIT
* CANCER GENETICS INC - REVERSE STOCK SPLIT WILL BE
EFFECTIVE FOR
TRADING PURPOSES ON OCTOBER 25, 2019
Source text for Eikon: ID:nGNX5Mn69g
Further company coverage: CGIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vyant Bio
See all newsBrief: Vyant Bio Provides Update On Winddown Activities
Brief: Vyant Bio Announces Stockholder Approval Of Plan Of Dissolution
Brief: Vyant Bio Files Form 15 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Filing Of Form 25 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Voluntary Nasdaq Delisting, SEC Deregistration